Asthmatic and non-asthmatic airway smooth muscle production of the mast cell chemotaxin CXCL10 involves MAPK Source: Eur Respir J 2006; 28: Suppl. 50, 854s Year: 2006
Transcriptional regulation of CXCL8 hypersecretion in asthmatic airway smooth muscle cells Source: Annual Congress 2009 - Airway cell biology Year: 2009
Rolipram and salmeterol block β1 /β2 -integrin-mediated adhesion of eosinophils to cultured airway smooth muscle cells from non-asthmatic and asthmatic donors Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003
Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism Source: International Congress 2017 – Novel mechanisms and treatments for asthma Year: 2017
Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002
Beta2-agonists but not glucocorticoids inhibit proliferation of asthmatic airway smooth muscle cells Source: Eur Respir J 2004; 24: Suppl. 48, 251s Year: 2004
The long-acting β2-agonist formoterol re-establishes the anti-proliferative effect of glucocorticoids in asthmatic airway smooth muscle cells (ASMC) Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011
Heme-oxygenase (HO)-1 inhibits TNF-α induced CXCL10 secretion by airway smooth muscle cells Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011
Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009
Omalizumab inhibits IgE-induced cytokine secretion by human airway smooth muscle cells Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1 Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016
IL-1β-induced MCP-1 production in human airway smooth muscle cells, modulation by dexamethasone, rolipram, and salbutamol Source: Eur Respir J 2001; 18: Suppl. 33, 353s Year: 2001
Anti-inflammatory effect of bosentan on endothelin-1- and TNF-α-induced GMCSF expression in human airways smooth muscle cells – role of MAPkinases ERK-1,-2 Source: Annual Congress 2007 - Inflammatory cell biology Year: 2007
Budesonide and formoterol differentially modulate the expression of C/EBP-alpha and calreticulin in airway smooth muscle (ASM) cells Source: Eur Respir J 2006; 28: Suppl. 50, 756s Year: 2006
Eotaxin/CCL11 inhibits proliferation of human airway smooth muscle cells Source: Eur Respir J 2005; 26: Suppl. 49, 127s Year: 2005
Glutathionylation of IκB-α inhibits NF-κB dependent chemokine secretion in airway smooth muscle cells Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010
TLR3/TAK1 signalling regulates rhinovirus-induced interleukin-33 in bronchial smooth muscle cells Source: ERJ Open Res, 6 (4) 00147-2020; 10.1183/23120541.00147-2020 Year: 2020
Bosentan blocks TNFα-induced GM-CSF expression in human airway smooth muscle cells Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in COPD Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010
Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013